Home / Understand Fragile X / Testing & Genetic Counselling

Clear information. Informed choices.

Testing &
genetic

counselling

Understanding a result begins with a conversation.

You may be exploring testing for yourself, your child, or someone in your family. You may already have a report and want to understand what it means.

Find a starting point, questions to ask, and Canadian resources to help you take the next step.

Your questions
belong in
the conversation.

On this page Considering testing The test Your report Testing in Canada Genetic counselling

DIFFERENT QUESTIONS TO ASK

Why consider testing?

A healthcare provider can help determine whether FMR1 testing is appropriate for your situation.


Development & learning

Developmental or learning differences, together with clinical features or family history, may prompt a conversation about Fragile X testing.


Your own
health

Certain concerns, such as unexplained early ovarian insufficiency or later-life tremor and balance changes, may lead a clinician to consider FMR1 testing.


Family information

A relative’s result may raise questions about your own health, inheritance, or reproductive choices.

ASK WHAT WAS ACTUALLY TESTED

Not all genetic tests
look for the same things.

FMR1 testing examines a repeating section of the gene to look for an expansion. Depending on the test and result, the laboratory may assess other features that help interpret it.

Microarray, exome, and genome tests differ in what they can detect. Some genome testing pathways include FMR1 repeat analysis; others do not.

MAKING SENSE OF THE INFORMATION

Understanding
your report

Ask for a copy of your laboratory report and an explanation in language that works for you.

A report can clarify a genetic finding. It cannot predict every aspect of someone’s health, development, or future.

A useful question to ask

“Did my previous testing specifically assess the FMR1 repeat expansion, and what could that test detect?”

A “normal genetic test” does not, by itself, tell you whether Fragile X was assessed. Your provider or laboratory can check the report and testing method.


FINDING YOUR WAY IN CANADA

Start with your provider.
Find your local pathway.

Ask your family doctor, nurse practitioner, or treating specialist about testing and access to genetic counselling.

Who can order a test, referral requirements, public coverage, and access to clinics vary by location and service.

Use a Canadian clinic directory, then confirm referral requirements, services, and any fees with the clinic. You do not need to arrange a laboratory test yourself to begin asking questions.

A conversation
centred on you.

UNDERSTANDING, SUPPORT & CHOICE

What can genetic
counselling help with?

A genetic counsellor or genetics team can help explain testing options and results, explore possible health and family implications, and support informed decisions.

You can discuss inheritance, reproductive choices, feelings about testing, and how to approach conversations with relatives.

The aim is to help you understand your options and make decisions that fit your values and circumstances.

TAKE WHAT IS USEFUL

Questions for your next conversation

Before testing

What question are we trying to answer?

Does this test assess the FMR1 repeat expansion?

What might the result mean for me or my family?

What are the costs, timing, and consent requirements?

After a result

Can you explain each part of my report?

What does the result tell us and what remains uncertain?

Do we need more information or another referral?

What follow-up is appropriate, and who will coordinate it?


Bring your questions, previous reports if available, and any relevant family information. It’s okay to ask for an explanation again or request a written summary.

YOU DON’T NEED TO NAVIGATE THIS ALONE

Let’s find your next step.

Fragile X Canada can help you find information and resources to explore.
Your healthcare provider or genetics team can interpret your individual results.

You don’t need to send medical records to start a conversation with us.